Ahmedabad (Gujarat) [India], November 14: Lincoln Pharmaceuticals Limited (BSE: 531633, NSE: LINCOLN), one of India's leading healthcare companies, has reported a consolidated net profit of Rs. 20.01 crore for the Q2 FY 2025-26. Total income for the quarter ended September 2025 was reported
Ahmedabad (Gujarat) [India], February 13: Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies, has reported a standalone net profit of Rs. 20.77 crore for the Q3 FY25 ended December 2024 as against a net profit of Rs. 28.04 crore in the corresponding period last year
Ahmedabad (Gujarat) [India], August 29: Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies has entered the elite league and Rs. 1,000 crore plus market capitalization companies club for the first time. Share price of the company hit a 52 week high of Rs. 513 per sha
Ahmedabad (Gujarat) [India], May 19 (ANI/PNN): Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies has reported its Best-ever results in a financial year with highest - Revenue, EBITDA and Net Profit for the FY ended March 2022. Company has recommended a dividend of